Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | CCKBR | P32239 | 10/20 | 0.55 |
| ▸ | CCKAR | P32238 | 5/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.51 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.51 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.51 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.51 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.51 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.51 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.51 |
| ▸ | GABRP | O00591 | 1/20 | 0.50 |
| ▸ | GABRD | O14764 | 1/20 | 0.50 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.50 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.50 |
| ▸ | GABRE | P78334 | 1/20 | 0.50 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL642305 | 1.00 | MEN1 (0.58) | MEN1ALDH1A1KMT2ACCKBRCCKAR | |
| SCHEMBL4700911 | 1.00 | MEN1 (0.58) | MEN1ALDH1A1KMT2ACCKBRCCKAR | |
| Bromide SCHEMBL8422518 | 0.98 | MEN1 (0.56) | MEN1ALDH1A1KMT2ACCKBRCCKAR | |
| Bromide SCHEMBL8422516 | 0.97 | MEN1 (0.55) | MEN1ALDH1A1KMT2ACCKBRCCKAR | |
| SCHEMBL8218620 | 0.89 | CCKBR (0.60) | MEN1ALDH1A1KMT2ACCKBRCCKAR | |
| SCHEMBL2526769 | 0.88 | CCKBR (0.56) | MEN1ALDH1A1KMT2ACCKBRCCKAR | |
| SCHEMBL18315499 | 0.88 | MEN1 (0.50) | MEN1ALDH1A1KMT2ACCKBRCCKAR | |
| SCHEMBL15629440 | 0.88 | MEN1 (0.50) | MEN1ALDH1A1KMT2ACCKBRCCKAR | |
| SCHEMBL19988836 | 0.88 | GABRA1 (0.51) | MEN1ALDH1A1KMT2ACCKBRCCKAR | |
| SCHEMBL6005722 | 0.85 | ALDH1A1 (0.50) | MEN1ALDH1A1KMT2ACCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12384764-B2 | Pharmaceutical compounds | PFIZER INC. (US) | 2025-08-12 | — | — | US | disclosed |
| US-12297209-B2 | Benzodiazepine derivatives as RSV inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| US-12268694-B2 | Combination pharmaceutical agents as RSV inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2025-04-08 | — | — | US | disclosed |
| CN-114787155-B | Pharmaceutical compounds | 辉瑞公司 | 2025-02-28 | — | — | CN | disclosed |
| US-12227507-B2 | Pharmaceutical compounds | PFIZER INC. (US) | 2025-02-18 | — | — | US | disclosed |
| CN-114761397-B | Benzodiazepine derivatives for the treatment of Respiratory Syncytial Virus (RSV) infection | 辉瑞公司 | 2024-11-05 | — | — | CN | disclosed |
| US-20240360117-A1 | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | ENANTA PHARM INC (US) | 2024-10-31 | — | — | US | disclosed |
| US-20240360155-A1 | Benzodiazepine Derivatives as RSV Inhibitors | ENANTA PHARM INC (US) | 2024-10-31 | — | — | US | disclosed |
| US-20240173332-A1 | BENZODIAZEPINES FOR TREATING OR PREVENTING RESPIRATORY SYNCYTIAL VIRUS INFECTION | PFIZER INC. (US) | 2024-05-30 | — | — | US | disclosed |
| US-11952389-B2 | Benzodiazepine derivatives as RSV inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2024-04-09 | — | — | US | disclosed |
| EP-0434369-A1 | New benzodiazepine analogs | MERCK & CO. INC. (US) | 1991-06-26 | — | — | EP | disclosed |
| EP-0434364-A2 | Benzodiazepine analogs for treating panic syndrome and for directly inducing analgesia | MERCK & CO. INC. (US) | 1991-06-26 | — | — | EP | disclosed |
| EP-0434360-A1 | New benziodiazepine analogs | MERCK & CO. INC. (US) | 1991-06-26 | — | — | EP | disclosed |
| EP-0421802-A2 | 3-substituted-1,4-benzodiazepines useful as oxytocin antagonists | MERCK & CO. INC. (US) | 1991-04-10 | — | — | EP | disclosed |
| US-5004741-A | Cholecystokinin(CCK); Treating Disorders Of The Gastrointestinal Tract, Central Nervous System And Of The Appetite Of Animals | MERCK & CO., INC. (US) | 1991-04-02 | — | — | US | disclosed |
| US-4970207-A | Benzodiazepine derivatives | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-11-13 | — | — | US | disclosed |
| EP-0349949-A2 | Benzodiazepine derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-01-10 | — | — | EP | disclosed |
| US-4820834-A | Benzodiazepine analogs | MERCK & CO., INC. (US) | 1989-04-11 | — | — | US | disclosed |
| EP-0284256-A1 | Benzodiazepine analogs | MERCK & CO. INC. (US) | 1988-09-28 | — | — | EP | disclosed |
| EP-0167919-A2 | Benzodiazepine derivatives and pharmaceutical compositions containing them | MERCK & CO. INC. (US) | 1986-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240173332-A1 | BENZODIAZEPINES FOR TREATING OR PREVENTING RESPIRATORY SYNCYTIAL VIRUS INFECTION | GABRA3, GABRA6, GABRA1 | MEN1 3936/4885ALDH1A1 2754/4885KMT2A 2739/4885 |
| US-12227507-B2 | Pharmaceutical compounds | CHRNA6, GABRA6, CHRNA7 | MEN1 3324/4885ALDH1A1 3480/4885KMT2A 3557/4885 |
| US-20240360155-A1 | Benzodiazepine Derivatives as RSV Inhibitors | GABRA5, GABRA1, GABBR2 | MEN1 3463/4885ALDH1A1 621/4885KMT2A 1493/4885 |
| US-11952389-B2 | Benzodiazepine derivatives as RSV inhibitors | GABRA5, GABRA1, GABBR2 | MEN1 3463/4885ALDH1A1 621/4885KMT2A 1493/4885 |
| US-12297209-B2 | Benzodiazepine derivatives as RSV inhibitors | GABRA5, GABRA1, GABBR2 | MEN1 3463/4885ALDH1A1 621/4885KMT2A 1493/4885 |
| US-20240360117-A1 | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | GABRA5, GABRA1, GABBR2 | MEN1 3463/4885ALDH1A1 621/4885KMT2A 1493/4885 |
| US-12268694-B2 | Combination pharmaceutical agents as RSV inhibitors | ACE, ACE2, SPCS3 | MEN1 3954/4885ALDH1A1 4172/4885KMT2A 3282/4885 |
| US-12384764-B2 | Pharmaceutical compounds | CNR1, HRH4, GABRA1 | MEN1 2262/4885ALDH1A1 2411/4885KMT2A 3475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.